Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedlineFRA:L10 +3.01%16 EV-to-FCF is 52.57 as of Jul. 29, 2026, which is 11% above its 10-year median of 47.23. GuruFocus rates FRA:L10 with a GF Score™ of 16/100. The stock has 3 warning signs investors should review. Among 417 Medical Devices & Instruments companies, Medline ranks worse than 78.66% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Medline's Enterprise Value is €46,386 Mil.
Medline's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was €882 Mil. Therefore, Medline's EV-to-FCF for today is 52.57.
The historical rank and industry rank for Medline's EV-to-FCF or its related term are showing as below:
FRA:L10'
s EV-to-FCF Range Over the Past 10 Years
Min: 40.2 Med: 47.23 Max: 79.89
Current: 51.26
During the past 4 years, the highest EV-to-FCF of Medline was 79.89. The lowest was 40.20. And the median was 47.23.
FRA:L10's EV-to-FCF is ranked worse than 78.66% of 417
companies
in the Medical Devices & Instruments industry
Industry Median: 23.13
vs FRA:L10: 51.26
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medline's share price for today is €34.20.
Medline's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.640.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Medline EV-to-FCF Related Terms
Medline EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Medline's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Medline's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medline EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medline's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Medline's EV-to-FCF falls into.
Medline's current Enterprise Value is €46,386 Mil.
Medline's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €882 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medline (FRA:L10) has a EV-to-FCF of 52.57 as of Jul. 29, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Medline and its competitors. This is 11% above median its historical median of 47.23. Over the past decade, Medline's EV-to-FCF has ranged from 40.20 to 79.89. According to the industry distribution chart, Medline ranks #328 out of 417 companies in the Medical Devices & Instruments industry, placing it in the top 78.7%.
Is Medline's EV-to-FCF too high?
Medline's current EV-to-FCF of 52.57 is 11% above median its 10-year median of 47.23. Over the past 10 years, this metric has ranged from a low of 40.20 to a high of 79.89. The Medical Devices & Instruments industry median EV-to-FCF is 23.13. Medline's value of 52.57 is 127.3% above this industry median. Based on the distribution chart, Medline ranks #328 out of 417 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Medline has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Medline's EV-to-FCF compare to RMD and WST?
According to the Medical Devices & Instruments industry distribution chart, Medline ranks #328 out of 417 companies for EV-to-FCF. This places Medline in the lower half of its industry. The industry median EV-to-FCF is 23.13. Medline's value of 52.57 is 127.3% above this benchmark. Historically, Medline's own EV-to-FCF has ranged from 40.20 to 79.89 over the past decade. While the company's 10-year median is 47.23 vs. the industry median of 23.13, Medline has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.13, based on 417 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medline's current EV-to-FCF of 52.57 is 127.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Medline and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medline's current EV-to-FCF is 52.57, which is 11% above median its own 10-year median of 47.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medline stock overvalued right now?
Medline (FRA:L10) has a current EV-to-FCF of 52.57. The current EV-to-FCF is 52.57, which is 11% above median its 10-year median of 47.23 and 127.3% above the Medical Devices & Instruments industry median of 23.13. Medline's overall GF Score™ is 16/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Medline (FRA:L10), the current EV-to-FCF is 52.57 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
16GF Score
Get the complete analysis for FRA:L10
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:L10 has been successfully added to your 
